David A. Dean, Ph.D.

See information for Patients. Viewing information for Researchers.

Contact

University of Rochester
School of Medicine and Dentistry
601 Elmwood Ave, Box 651
Rochester, New York 14642

Office: 585 276-3933

Office: 585 756-7780

Lab: 585 275-3577

Portrait

Despite all of the hype regarding gene therapy, at present, gene therapy is a dream due to insufficient levels of gene transfer and expression at desired sites. One way to increase gene expression is to target more DNA to the cell nucleus. Since the nucleus is the site of transcription, without the movement of plasmids through the cytoplasm, translocation into the nucleus, and localization to the appropriate subnuclear domain, no gene expression, or "gene therapy" can take place. Ongoing projects in my laboratory are studying the mechanisms of cytoplasmic trafficking of plasmids along the cytoskeleton, plasmid nuclear entry, subnuclear organization, and exploiting what we learn to improve gene therapy.

We have shown that plasmids are able to enter the nucleus in a sequence-specific manner that appears to be mediated by transcription factor binding. My lab is interested in identifying the proteins required for this activity and the regulation of their nuclear import. Based on our model, we have created cell-specific plasmids by incorporating DNA sequences that bind to cell-specific transcription factors. At present, we have examples of smooth muscle, alveolar epithelial cell, and endothelial cell-targeting vectors that we hope to use for the treatment of a number of pulmonary diseases, and we are working to expand our repertoire to selectively target expression to any desired cell or tissue.

We also are developing methods for extracellular delivery of non-viral vectors in animal models for disease. Using electroporation, we have obtained very high levels of gene expression in the vasculature and lungs of animals. We have used this approach to prevent and/or cure existing disease in models of acute lung injury and asthma in mice and rats. Our next goal is to optimize these approaches in more relevant preclinical models to move toward clinical application.

Specialty

Neonatology

Current Appointments

Education
PhD Microbiology University of California at Berkeley 1990
BA Biochemistry University of California at San Diego 1985
Post-Doctoral Training & Residency
University of California, Los Angeles Postdoctoral Fellow Virology 1990 - 1994
Recent Journal Articles
Showing the 5 most recent journal articles. (54 available)
Young, J. L., W. E. Zimmer, and D. A. Dean. "Smooth muscle-specific gene delivery in the vasculature based on restriction of DNA nuclear import." J Gene Medicine (in revision). (2007).
Munkonge, F. M., V. Amin, J.Smith, R. Hooley, S. Xenariou, C. Nixon, M. A. Ward, N. Leeds, K.-Y. Leung, E. Hillery, U. Griesenbach, D. M. Geddes, E. H. Postel, D. A. Dean, M. J. Dunn, and E.W.F.W Alton. "Identification and Functional Characterisation of Cytoplasmic Determinants of Plasmid DNA Nuclear Import." Mol Cell Biol (in revision) (2007).
Capaccio, C., N. S. Stoykov, R. Sundararajan, and D. A. Dean. "Quantifying Induced Electric Field Strengths During Gene Transfer to the Intact Rat Vasculature." IEEE Trans. Biomed. Eng. (in revision). (2007).
Lam, A. P.; Dean, DA. "Cyclic stretch-induced nuclear localization of transcription factors results in increased nuclear targeting of plasmids in alveolar epithelial cells." Mol Therapy (submitted). (2007).
DeGiulio, J. V., and D. A. Dean. "Alveolar Epithelial Cell-Specific Plasmid Nuclear Import." Gene Therapy (submitted) (2007).